In the PD model, PT significantly ameliorated dopaminergic neuronal degeneration and inhibited activation of NLRP3 inflammatory vesicles in the substantia nigra, alleviating the PD phenotype [18]. The gene discussed is NLRP3; the disease is Parkinson disease.